Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1642392

Cover Image

PUBLISHER: Fairfield Market Research | PRODUCT CODE: 1642392

Small Molecule CMO/CDMO Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032

PUBLISHED:
PAGES: 157 Pages
DELIVERY TIME: 2-5 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4995
Unprintable PDF & Excel (Multi User License upto 5 users)
USD 8495
Printable PDF & Excel (Enterprise License above 5 users)
USD 10600

Add to Cart

Description

Table of Contents

The Small Molecule CMO/CDMO (Contract Manufacturing Organization/Contract Development and Manufacturing Organization) market is a critical component of the pharmaceutical industry, focusing on outsourcing services for small molecule drug production. These specialized organizations enable pharmaceutical companies to optimize their operations, reduce costs, and accelerate drug development timelines.

Market Insights

The Small Molecule CMO/CDMO market is poised for substantial growth, driven by increasing demand for outsourcing in the pharmaceutical sector. By 2025, the market is expected to reach USD 79.08 billion, and by 2032, it is projected to grow to USD 109.81 billion, with a compound annual growth rate (CAGR) of 4.80%. The adoption of advanced technologies and the shift toward outsourcing key development and manufacturing processes are pivotal in driving this growth.

Key Market Drivers

  • 1. Rising Demand for Specialized Services: The complexity of small molecule drug development has created a need for specialized expertise and infrastructure, which CMO/CDMOs are uniquely positioned to offer.
  • 2. Cost Optimization: Pharmaceutical companies are increasingly outsourcing production to reduce operational costs and focus on core competencies, driving demand for CMO/CDMO services.
  • 3. Technological Advancements: The integration of innovative technologies such as continuous manufacturing, artificial intelligence, and process analytical technology (PAT) is enhancing operational efficiency and reducing production costs.

Business Opportunities

  • 1. Specialized Drug Production: The demand for niche and specialty drugs, including therapies for rare diseases and personalized medicine, offers significant opportunities for CMO/CDMOs to cater to this growing market segment.
  • 2. Adoption of Advanced Manufacturing Technologies: Investments in cutting-edge manufacturing technologies provide a competitive edge and attract pharmaceutical companies seeking efficient and cost-effective solutions.

Regional Analysis

  • 1. Europe: A dominant region in the market, Europe's strong pharmaceutical manufacturing capabilities and adherence to stringent regulatory standards position it as a key player in the global market.
  • 2. South Asia & Pacific: Emerging as the fastest-growing region, South Asia & Pacific benefits from strategic investments, a favorable regulatory environment, and cost-effective manufacturing solutions.

Key Players

Prominent players in the Small Molecule CMO/CDMO market include:

Pfizer CentreOne

Baxter BioPharma Solutions

Catalent

Lonza

Syngene International

Boehringer Ingelheim

Piramal Pharma Solutions

Wuxi AppTec

Patheon (Thermo Fisher Scientific Inc.)

Adare Pharma Solutions

Ajinomoto Bio-Pharma Services

These companies leverage competitive intelligence, technological advancements, and strategic partnerships to strengthen their market positions.

Challenges and Restraints

  • 1. Regulatory Compliance: Adhering to stringent and evolving regulatory standards is a key challenge for CMO/CDMOs, which can lead to increased costs and potential delays.
  • 2. Global Supply Chain Disruptions: Raw material shortages, transportation bottlenecks, and geopolitical uncertainties pose significant risks to the smooth operation of pharmaceutical supply chains.

Recent Developments

  • 1. Adare Pharma Solutions: In July 2023, Adare Pharma Solutions divested its Adare Biome business unit to DSM-Firmenich, aligning its portfolio to focus on core strengths and operational efficiency.
  • 2. Catalent: In June 2023, Catalent expanded its One Bio Suite solution to include biotechnological modalities such as antibody and recombinant proteins, cellular and gene therapy, and mRNA. This strategic initiative positions Catalent as a comprehensive service provider in the CMO/CDMO Analysis.

Market Segmentation

The Small Molecule CMO/CDMO market can be segmented as follows:

1. By Product:

    Standard API HPAPI (High Potency Active Pharmaceutical Ingredients)

2. By Service:

    Process Development Analytical Method Development GMP Manufacturing Service Scale-Up and Tech Transfer Quality Control and Quality Assurance Regulatory Assistance Technology and Innovation

3. By Company Size:

    Large Companies Mid-Sized Companies Small Companies

4. By Scale of Operation:

    Clinical Phase I Phase II Phase III Commercial

5. By Region:

    North America Europe Asia Pacific Latin America Middle East & Africa
Show more

Table of Contents

1. Executive Summary

  • 1.1. Global Small Molecule CMO/CDMO Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Small Molecule CMO/CDMO Market Outlook, 2019 - 2032

  • 3.1. Global Small Molecule CMO/CDMO Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
    • 3.1.1. Key Highlights
      • 3.1.1.1. Standard API
      • 3.1.1.2. HPAPI
  • 3.2. Global Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
    • 3.2.1. Key Highlights
      • 3.2.1.1. Process Development
      • 3.2.1.2. Analytical Method Development
      • 3.2.1.3. GMP Manufacturing Service
      • 3.2.1.4. Scale-Up and Tech Transfer
      • 3.2.1.5. Quality Control and Quality Assurance
      • 3.2.1.6. Regulatory Assistance
      • 3.2.1.7. Technology and Innovation
  • 3.3. Global Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019 - 2032
    • 3.3.1. Key Highlights
      • 3.3.1.1. Large
      • 3.3.1.2. Mid-sized
      • 3.3.1.3. Small
  • 3.4. Global Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 3.4.1. Key Highlights
      • 3.4.1.1. Clinical
        • 3.4.1.1.1. Phase I
        • 3.4.1.1.2. Phase II
        • 3.4.1.1.3. Phase III
      • 3.4.1.2. Commercial
  • 3.5. Global Small Molecule CMO/CDMO Market Outlook, by Region, Value (US$ Bn), 2019 - 2032
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Small Molecule CMO/CDMO Market Outlook, 2019 - 2032

  • 4.1. North America Small Molecule CMO/CDMO Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Standard API
      • 4.1.1.2. HPAPI
  • 4.2. North America Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Process Development
      • 4.2.1.2. Analytical Method Development
      • 4.2.1.3. GMP Manufacturing Service
      • 4.2.1.4. Scale-Up and Tech Transfer
      • 4.2.1.5. Quality Control and Quality Assurance
      • 4.2.1.6. Regulatory Assistance
      • 4.2.1.7. Technology and Innovation
  • 4.3. North America Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Large
      • 4.3.1.2. Mid-sized
      • 4.3.1.3. Small
  • 4.4. North America Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. Clinical
        • 4.4.1.1.1. Phase I
        • 4.4.1.1.2. Phase II
        • 4.4.1.1.3. Phase III
      • 4.4.1.2. Commercial
    • 4.4.2. BPS Analysis/Market Attractiveness Analysis
  • 4.5. North America Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 4.5.1.2. U.S. Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 4.5.1.3. U.S. Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 4.5.1.4. U.S. Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 4.5.1.5. Canada Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 4.5.1.6. Canada Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 4.5.1.7. Canada Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 4.5.1.8. Canada Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Small Molecule CMO/CDMO Market Outlook, 2019 - 2032

  • 5.1. Europe Small Molecule CMO/CDMO Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Standard API
      • 5.1.1.2. HPAPI
  • 5.2. Europe Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Process Development
      • 5.2.1.2. Analytical Method Development
      • 5.2.1.3. GMP Manufacturing Service
      • 5.2.1.4. Scale-Up and Tech Transfer
      • 5.2.1.5. Quality Control and Quality Assurance
      • 5.2.1.6. Regulatory Assistance
      • 5.2.1.7. Technology and Innovation
  • 5.3. Europe Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Large
      • 5.3.1.2. Mid-sized
      • 5.3.1.3. Small
  • 5.4. Europe Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. Clinical
        • 5.4.1.1.1. Phase I
        • 5.4.1.1.2. Phase II
        • 5.4.1.1.3. Phase III
      • 5.4.1.2. Commercial
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis
  • 5.5. Europe Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 5.5.1.2. Germany Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 5.5.1.3. Germany Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 5.5.1.4. Germany Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 5.5.1.5. U.K. Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 5.5.1.6. U.K. Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 5.5.1.7. U.K. Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 5.5.1.8. U.K. Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 5.5.1.9. France Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 5.5.1.10. France Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 5.5.1.11. France Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 5.5.1.12. France Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 5.5.1.13. Italy Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 5.5.1.14. Italy Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 5.5.1.15. Italy Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 5.5.1.16. Italy Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 5.5.1.17. Turkey Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 5.5.1.18. Turkey Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 5.5.1.19. Turkey Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 5.5.1.20. Turkey Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 5.5.1.21. Russia Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 5.5.1.22. Russia Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 5.5.1.23. Russia Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 5.5.1.24. Russia Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 5.5.1.25. Rest of Europe Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 5.5.1.26. Rest of Europe Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 5.5.1.27. Rest of Europe Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 5.5.1.28. Rest of Europe Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Small Molecule CMO/CDMO Market Outlook, 2019 - 2032

  • 6.1. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Standard API
      • 6.1.1.2. HPAPI
  • 6.2. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Process Development
      • 6.2.1.2. Analytical Method Development
      • 6.2.1.3. GMP Manufacturing Service
      • 6.2.1.4. Scale-Up and Tech Transfer
      • 6.2.1.5. Quality Control and Quality Assurance
      • 6.2.1.6. Regulatory Assistance
      • 6.2.1.7. Technology and Innovation
  • 6.3. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Large
      • 6.3.1.2. Mid-sized
      • 6.3.1.3. Small
  • 6.4. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Clinical
        • 6.4.1.1.1. Phase I
        • 6.4.1.1.2. Phase II
        • 6.4.1.1.3. Phase III
      • 6.4.1.2. Commercial
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis
  • 6.5. Asia Pacific Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 6.5.1.2. China Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 6.5.1.3. China Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 6.5.1.4. China Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 6.5.1.5. Japan Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 6.5.1.6. Japan Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 6.5.1.7. Japan Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 6.5.1.8. Japan Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 6.5.1.9. South Korea Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 6.5.1.10. South Korea Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 6.5.1.11. South Korea Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 6.5.1.12. South Korea Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 6.5.1.13. India Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 6.5.1.14. India Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 6.5.1.15. India Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 6.5.1.16. India Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 6.5.1.17. Southeast Asia Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 6.5.1.18. Southeast Asia Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 6.5.1.19. Southeast Asia Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 6.5.1.20. Southeast Asia Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 6.5.1.21. Rest of Asia Pacific Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 6.5.1.22. Rest of Asia Pacific Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 6.5.1.23. Rest of Asia Pacific Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 6.5.1.24. Rest of Asia Pacific Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Small Molecule CMO/CDMO Market Outlook, 2019 - 2032

  • 7.1. Latin America Small Molecule CMO/CDMO Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Standard API
      • 7.1.1.2. HPAPI
  • 7.2. Latin America Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Process Development
      • 7.2.1.2. Analytical Method Development
      • 7.2.1.3. GMP Manufacturing Service
      • 7.2.1.4. Scale-Up and Tech Transfer
      • 7.2.1.5. Quality Control and Quality Assurance
      • 7.2.1.6. Regulatory Assistance
      • 7.2.1.7. Technology and Innovation
  • 7.3. Latin America Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Large
      • 7.3.1.2. Mid-sized
      • 7.3.1.3. Small
  • 7.4. Latin America Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. Clinical
        • 7.4.1.1.1. Phase I
        • 7.4.1.1.2. Phase II
        • 7.4.1.1.3. Phase III
      • 7.4.1.2. Commercial
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis
  • 7.5. Latin America Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 7.5.1.2. Brazil Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 7.5.1.3. Brazil Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 7.5.1.4. Brazil Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 7.5.1.5. Mexico Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 7.5.1.6. Mexico Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 7.5.1.7. Mexico Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 7.5.1.8. Mexico Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 7.5.1.9. Argentina Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 7.5.1.10. Argentina Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 7.5.1.11. Argentina Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 7.5.1.12. Argentina Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 7.5.1.13. Rest of Latin America Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 7.5.1.14. Rest of Latin America Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 7.5.1.15. Rest of Latin America Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 7.5.1.16. Rest of Latin America Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, 2019 - 2032

  • 8.1. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Product, Value (US$ Bn), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Standard API
      • 8.1.1.2. HPAPI
  • 8.2. Middle East & Africa Middle East & Africa al Small Molecule CMO/CDMO Market Outlook, by Service, Value (US$ Bn), 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Process Development
      • 8.2.1.2. Analytical Method Development
      • 8.2.1.3. GMP Manufacturing Service
      • 8.2.1.4. Scale-Up and Tech Transfer
      • 8.2.1.5. Quality Control and Quality Assurance
      • 8.2.1.6. Regulatory Assistance
      • 8.2.1.7. Technology and Innovation
  • 8.3. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Company Size, Value (US$ Bn), 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Large
      • 8.3.1.2. Mid-sized
      • 8.3.1.3. Small
  • 8.4. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Clinical
        • 8.4.1.1.1. Phase I
        • 8.4.1.1.2. Phase II
        • 8.4.1.1.3. Phase III
      • 8.4.1.2. Commercial
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis
  • 8.5. Middle East & Africa Small Molecule CMO/CDMO Market Outlook, by Country, Value (US$ Bn), 2019 - 2032
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 8.5.1.2. GCC Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 8.5.1.3. GCC Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 8.5.1.4. GCC Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 8.5.1.5. South Africa Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 8.5.1.6. South Africa Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 8.5.1.7. South Africa Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 8.5.1.8. South Africa Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 8.5.1.9. Egypt Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 8.5.1.10. Egypt Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 8.5.1.11. Egypt Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 8.5.1.12. Egypt Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 8.5.1.13. Nigeria Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 8.5.1.14. Nigeria Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 8.5.1.15. Nigeria Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 8.5.1.16. Nigeria Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
      • 8.5.1.17. Rest of Middle East & Africa Small Molecule CMO/CDMO Market by Product, Value (US$ Bn), 2019 - 2032
      • 8.5.1.18. Rest of Middle East & Africa Small Molecule CMO/CDMO Market by Service, Value (US$ Bn), 2019 - 2032
      • 8.5.1.19. Rest of Middle East & Africa Small Molecule CMO/CDMO Market by Company Size, Value (US$ Bn), 2019 - 2032
      • 8.5.1.20. Rest of Middle East & Africa Small Molecule CMO/CDMO Market by Scale of Operation, Value (US$ Bn), 2019 - 2032
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Market Share Analysis, 2024
  • 9.2. Competitive Dashboard
  • 9.3. Company Profiles
    • 9.3.1. Adare Pharma Solutions
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Product Portfolio
      • 9.3.1.3. Financial Overview
      • 9.3.1.4. Business Strategies and Development
    • 9.3.2. Ajinomoto Bio-Pharma Services
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Product Portfolio
      • 9.3.2.3. Financial Overview
      • 9.3.2.4. Business Strategies and Development
    • 9.3.3. Ascendia Pharma
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Product Portfolio
      • 9.3.3.3. Financial Overview
      • 9.3.3.4. Business Strategies and Development
    • 9.3.4. Asymchem
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Product Portfolio
      • 9.3.4.3. Financial Overview
      • 9.3.4.4. Business Strategies and Development
    • 9.3.5. August Bioservices
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Product Portfolio
      • 9.3.5.3. Financial Overview
      • 9.3.5.4. Business Strategies and Development
    • 9.3.6. Baxter BioPharma Solutions
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Product Portfolio
      • 9.3.6.3. Financial Overview
      • 9.3.6.4. Business Strategies and Development
    • 9.3.7. Cambrex
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Product Portfolio
      • 9.3.7.3. Financial Overview
      • 9.3.7.4. Business Strategies and Development
    • 9.3.8. Catalent
      • 9.3.8.1. Company Overview
      • 9.3.8.2. Product Portfolio
      • 9.3.8.3. Financial Overview
      • 9.3.8.4. Business Strategies and Development
    • 9.3.9. Lonza
      • 9.3.9.1. Company Overview
      • 9.3.9.2. Product Portfolio
      • 9.3.9.3. Financial Overview
      • 9.3.9.4. Business Strategies and Development
    • 9.3.10. Thermo Fisher Scientific
      • 9.3.10.1. Company Overview
      • 9.3.10.2. Product Portfolio
      • 9.3.10.3. Financial Overview
      • 9.3.10.4. Business Strategies and Development
    • 9.3.11. Nanoform
      • 9.3.11.1. Company Overview
      • 9.3.11.2. Product Portfolio
      • 9.3.11.3. Financial Overview
      • 9.3.11.4. Business Strategies and Development
    • 9.3.12. PCI Pharma Services
      • 9.3.12.1. Company Overview
      • 9.3.12.2. Product Portfolio
      • 9.3.12.3. Financial Overview
      • 9.3.12.4. Business Strategies and Development
    • 9.3.13. Quotient Sciences
      • 9.3.13.1. Company Overview
      • 9.3.13.2. Product Portfolio
      • 9.3.13.3. Financial Overview
      • 9.3.13.4. Business Strategies and Development
    • 9.3.14. Societal(TM) CDMO
      • 9.3.14.1. Company Overview
      • 9.3.14.2. Product Portfolio
      • 9.3.14.3. Financial Overview
      • 9.3.14.4. Business Strategies and Development
    • 9.3.15. Syngene International
      • 9.3.15.1. Company Overview
      • 9.3.15.2. Product Portfolio
      • 9.3.15.3. Financial Overview
      • 9.3.15.4. Business Strategies and Development
    • 9.3.16. Siegfried Holding AG
      • 9.3.16.1. Company Overview
      • 9.3.16.2. Product Portfolio
      • 9.3.16.3. Financial Overview
      • 9.3.16.4. Business Strategies and Development
    • 9.3.17. Boehringer Ingelheim
      • 9.3.17.1. Company Overview
      • 9.3.17.2. Product Portfolio
      • 9.3.17.3. Financial Overview
      • 9.3.17.4. Business Strategies and Development
    • 9.3.18. Piramal Pharma Solutions
      • 9.3.18.1. Company Overview
      • 9.3.18.2. Product Portfolio
      • 9.3.18.3. Financial Overview
      • 9.3.18.4. Business Strategies and Development
    • 9.3.19. CordenPharma International
      • 9.3.19.1. Company Overview
      • 9.3.19.2. Product Portfolio
      • 9.3.19.3. Financial Overview
      • 9.3.19.4. Business Strategies and Development
    • 9.3.20. Wuxi AppTec
      • 9.3.20.1. Company Overview
      • 9.3.20.2. Product Portfolio
      • 9.3.20.3. Financial Overview
      • 9.3.20.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!